CD4 and neoplasm: In addition, naive CD4+ T cells from CD45.1 OT-II donors were adoptively transferred into congenic CD45.2 Havcr1BKO, in which tumour-derived CD45.1+CD4+ T cells showed increased IFNγ expression and reduced FOXP3 expression.